Genome-wide analysis of gene expression and protein secretion of Babesia canis during virulent infection identifies potential pathogenicity factors by Eichenberger, Ramon M et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Genome-wide analysis of gene expression and protein secretion of Babesia
canis during virulent infection identifies potential pathogenicity factors
Eichenberger, Ramon M; Ramakrishnan, Chandra; Russo, Giancarlo; Deplazes, Peter; Hehl, Adrian B
DOI: https://doi.org/10.1038/s41598-017-03445-x
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-138138
Published Version
 
 
Originally published at:
Eichenberger, Ramon M; Ramakrishnan, Chandra; Russo, Giancarlo; Deplazes, Peter; Hehl, Adrian B
(2017). Genome-wide analysis of gene expression and protein secretion of Babesia canis during virulent
infection identifies potential pathogenicity factors. Scientific Reports, 7(1):1-14.
DOI: https://doi.org/10.1038/s41598-017-03445-x
1Scientific RepoRts | 7: 3357  | DOI:10.1038/s41598-017-03445-x
www.nature.com/scientificreports
Genome-wide analysis of gene 
expression and protein secretion 
of Babesia canis during virulent 
infection identifies potential 
pathogenicity factors
Ramon M. Eichenberger1, Chandra Ramakrishnan1, Giancarlo Russo2, Peter Deplazes1 & 
Adrian B. Hehl1
Infections of dogs with virulent strains of Babesia canis are characterized by rapid onset and high 
mortality, comparable to complicated human malaria. As in other apicomplexan parasites, most 
Babesia virulence factors responsible for survival and pathogenicity are secreted to the host cell 
surface and beyond where they remodel and biochemically modify the infected cell interacting with 
host proteins in a very specific manner. Here, we investigated factors secreted by B. canis during 
acute infections in dogs and report on in silico predictions and experimental analysis of the parasite’s 
exportome. As a backdrop, we generated a fully annotated B. canis genome sequence of a virulent 
Hungarian field isolate (strain BcH-CHIPZ) underpinned by extensive genome-wide RNA-seq analysis. 
We find evidence for conserved factors in apicomplexan hemoparasites involved in immune-evasion 
(e.g. VESA-protein family), proteins secreted across the iRBC membrane into the host bloodstream 
(e.g. SA- and Bc28 protein families), potential moonlighting proteins (e.g. profilin and histones), 
and uncharacterized antigens present during acute crisis in dogs. The combined data provides a first 
predicted and partially validated set of potential virulence factors exported during fatal infections, 
which can be exploited for urgently needed innovative intervention strategies aimed at facilitating 
diagnosis and management of canine babesiosis.
Apicomplexan parasites have evolved a plethora of targeted interactions with their host organisms and cellular 
machinery to elicit modification of gene expression and cellular functions. These modifications are critical for 
invasion and for establishment of intracellular niches for parasite replication, differentiation, and persistence, by 
securing nutrient import and mediating immune evasion1. As a result, host-parasite relationships in intracellular 
Apicomplexa can be viewed as co-adaptations driven by co-evolution of parasites with their hosts2. Most impor-
tantly, this complex interplay is directly linked to pathogenicity and virulence which characterize symptomatic 
infections with these protozoan parasites3–8.
Three genera of this phylum represent a triad of phylogenetically related hemoprotozoa: Plasmodium (human 
and animal malaria), Theileria (theileriosis in livestock), and Babesia (severe disease and death in cattle, horses, 
dogs, with some zoonotic potential). They are the causative agents of important human and/or animal diseases 
with high morbidity and mortality, responsible for significant economic burdens and healthcare challenges 
worldwide9. The clinically relevant part of the complex, heteroxenous Babesia life cycle takes place during asexual 
proliferation of parasites in red blood cells (RBC) of the mammalian intermediate host. This represents a distinct 
specialization of Babesia for growth in RBC, i.e. cells which lack organelles, as well as endocytic and exocytic 
membrane transport machinery10, 11.
Canine babesiosis is an emerging tick-borne disease of dogs with global distribution caused by morpho-
logically distinctive Babesia species12–14. The geographical distribution of the disease caused by B. canis, the 
species responsible for a virulent form of canine babesiosis in Europe and Western Asia, appears to extend, as 
1Institute of Parasitology, University of Zurich, Zurich, Switzerland. 2Functional Genomics Center Zurich, Zurich, 
Switzerland. Correspondence and requests for materials should be addressed to A.B.H. (email: adrian.hehl@uzh.ch)
Received: 11 January 2017
Accepted: 27 April 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 3357  | DOI:10.1038/s41598-017-03445-x
demonstrated by an increasing number of cases in areas outside of the established endemic regions15. The clinical 
spectrum of B. canis babesiosis is broad, ranging from apparently silent, mild disease to fulminant and often fatal 
presentations14. Indeed, in many respects canine babesiosis is highly comparable to clinical human malaria16, 17.
Analysis of correlated genomic, transcriptomic and proteomic data lays out the molecular underpinning for 
investigating the role of exported factors in disease manifestation and progression. However, experimental inves-
tigation of B. canis biology is limited by the current lack of cultivation techniques for propagation of this parasite 
in vitro. Here, we implemented short term in vitro cultivation of infected RBC in combination with whole genome 
sequencing, annotation, and comparative genomic characterization of a virulent Hungarian B. canis field isolate. 
By correlating RNA-seq and protein mass spectrometry data, we provide the first account of factors exported by 
B. canis blood stages with potential links to host-pathogen interaction and acute virulence.
Results
Genome sequence of a virulent Babesia canis strain. Until recently, only a few genes from canine 
Babesia species have been characterized and global genomic data were not available. To provide the molecular 
underpinning for targeted approaches to diagnosis, vaccination and clinical management of canine babesiosis 
we undertook complete sequencing, assembly, annotation and characterization of the genome of a virulent B. 
canis strain, designated BcH-CHIPZ. The BcH-CHIPZ isolate originated from the blood of a Swiss dog that was 
infected, presumably through the bite of an infected tick, during a trip to Hungary. The isolate was characterized 
by genotyping and identified as double B-type by restriction fragment length polymorphism (RFLP) analysis 
in the Bc28-multigene family and the 18S rRNA gene18. We implemented a next-generation high throughput 
approach (PacBio® SMRT) for sequencing BcH-CHIPZ genomic DNA prepared after enrichment of infected 
RBCs (iRBCs). Assembly of the parasite-specific sequence reads after elimination of all reads from host DNA 
and gap-filling yielded 43 high-quality scaffolds at 55-fold average coverage representing a total of 7′002′180 
bases with a median weighted contig size (N50) of 185 kb. Hence, the size of the B. canis genome lies between the 
phylogenetically related B. microti (6.5 Mb) and the B. bovis (8.2 Mb) genomes19, 20. The main features of the anno-
tated B. canis genome and a comparison with other apicomplexan genomes are presented in Table 1. The quality 
of this assembly, based on the presence of core eukaryotic genes21, 22, indicates the B. canis genome sequence to be 
92.6% complete as compared with the genome of the T. gondii ME49 type II reference strain23 and consistent with 
values of other Babesia genome sequences, which lie between 91.7% and 95.6% (Supplementary Document S1). 
A robust annotation of species-specific gene models was based on the analysis of orthologues as well as on syn-
teny in related species (described below). Furthermore, whole genome mapping approach allowed contiguous 
alignment of the B. canis scaffolds with the 4 B. bovis chromosomes. This indicated a high degree of synteny with 
B. bovis chromosomes (Fig. 1).
Genome-wide comparison of B. canis gene models with those of other Apicomplexa reveals 
species-specific genes. The B. canis gene models were grouped into orthologues in four representative 
apicomplexan parasites B. bovis, Th. annulata, P. falciparum, and T. gondii and the fully sequenced Babesia 
species B. bovis, B. bigemina, and B. microti using a Markov Cluster algorithm in OrthoMCL (Fig. 2A,B). The 
four Babesia species analysed here share a core set of 1216 pan-Babesia conserved orthologous groups (COG) 
(Supplementary Data S1). However, bovine and rodent Babesia genomes also share 1030 COGs which are not 
represented in the B. canis genome (Supplementary Data S2). The former and the pan-Babesia COGs together 
contain a high percentage of clusters with hypothetical proteins (46.9% and 38.1%, respectively), which is not sur-
prising given the overall high proportions of proteins annotated as “hypothetical” (61.8% in B. bigemina, 49.9% 
in B. bovis, and 50.2% in B. canis). However, there was no specific enrichment with respect to protein domains 
and functions between the two groups. Functional classification of the 95 clusters unique to B. canis highlights 
potential species-specific innovations comprised of proteins annotated as “hypothetical” proteins (55.8%), surface 
proteins (proteins with VESA1-domains and merozoite surface antigen; 26.4%), a number of specified secreted 
proteins (9%), and various other proteins (8.6%) (Supplementary data S3). Analysis of the bovine Babesia shared 
Features
Species
B. canis 
[BcH-
CHIPZ]
B. bovis 
[T2Bo]
B. microti 
[RI]
Th. annulata 
[Ankara]
P. falciparum 
[3D7]
Genome size (Mb) 7.0 8.2 6.5 8.4 23.3
# of chromosomes 4 4 4 4 14
# of scaffolds 43 12 3 7 14
G + C content (%) 45.8 41.5 36 32.5 19.4
Protein coding 
genes 3467 3706 3513 4082 5383
Mean gene size 
(bp)1 1044 1503 1327 1602 2292
% of coding 
regions 51.7 68 73 73 53
Gene density2 2020 2194 1816 2199 4374
Table 1. Genome characteristics of related apicomplexan hemoprotozoa (more information is provided in 
Supplementary Document S2). 1Excluding introns and UTRs; 2Genome size/number of protein coding genes.
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orthologues revealed hypothetical proteins in 76.2% of the clusters analysed and predicted membrane proteins 
in 8.2% of the gene models. Prima facie, we interpret the diverged set of annotated genes in the different Babesia 
species as a reflection of the narrow and highly specific host range and a high degree of specialization for their 
respective vertebrate- and arthropod niches. This is based on the assumption that the diversity of encoded pro-
teins is inversely correlated with the degree of specialization for different environments, niches, and lifestyles of 
a parasite, thus reflecting lineage-specific adaptations24, 25. Nevertheless, with 347 genes/Mb, the B. canis genome 
has a similar gene density as the B. bovis (372 genes/Mb) and the B. microti (354 genes/Mb) genomes, albeit some 
regions appear to have higher density than others (Fig. 1).
Despite significant species-specific features, analysis of orthologues revealed a considerable degree of synteny 
between the genomes of B. canis and B. bovis compared with the genome of the rodent B. microti (Fig. 1). This is 
also reflected in the phylogenetic analysis based on a core set of 975 shared genes in representative apicomplexan 
parasites (Fig. 2B,C).
Prediction of the B. canis exportome and analysis of mRNA expression levels. Exported proteins 
of apicomplexan parasites include virulence factors, i.e. parasite-specific proteins which interfere directly with 
host cell functions. As mature RBC lack de novo protein synthesis or trafficking pathways, membrane transport 
machinery for targeting these proteins via the cytoplasm to the iRBC surface and beyond are provided by the 
parasite. These parasite-induced cytoplasmic alterations of iRBC are critical for its development and directly 
Figure 1. Genome characteristics of Babesia species. Assembled B. canis contigs (top arc) were arranged based 
on synteny to related Babesia species. The predicted arrangement of B. canis contigs on four chromosomes is 
indicated by colours of the lines linking conserved genes. Blood stage mRNA expression data for B. canis genes 
is included (line plot); gene density is colour coded and represented as number of genes per 10 kb (heatmap). 
Chromosomal distribution of B. canis VESA gene models is indicated with red dots.
www.nature.com/scientificreports/
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linked to the severity of babesiosis26. As a first step to characterize parasite-secreted factors and surface proteins, 
we generated a predicted B. canis exportome based on the annotated BcH-CHIPZ genome. We used data mining 
tools to search for genes coding for predicted parasite surface- or iRBC-targeted factors. The criteria and pri-
oritization for this selection were based on the presence of a canonical hydrophobic N-terminal signal peptide 
(cSP) sequence, an alternative non-classical secretion pathway (a/ncSP) signal, predicted transmembrane (TM) 
domain(s), a GPI anchor signal, or previously described domains of conserved apicomplexan secretory proteins 
and protein families (Supplementary Fig. S1; Supplementary Data S4). By this approach we generated a curated 
and parsed list of 509 genes coding for proteins that are predicted to be exported to the parasite surface and/or to 
the host, which corresponds to 14.6% of all B. canis gene models. This proportion is very similar to the 528 gene 
models (14%) representing the predicted B. bovis secretome27.
All Apicomplexa express members of gene families that are exported to the surface of invasive stages or the 
plasma membrane of iRBC where they interact with the host immune system28. Members of the Babesia var-
iant erythrocyte surface antigen (VESA) family on the surface of iRBCs29 comprise the largest protein family 
in B. canis (103 gene models) in the predicted exportome (Fig. 3A). Most VESA genes cluster together on few 
contigs, unlike other gene families of the predicted exportome which are distributed more randomly (Fig. 1). 
Furthermore, VESA genes are in regions of the genome with high gene density, suggesting frequent gene dupli-
cation events consistent with a driving selection pressure on these proteins associated with immune-evasion. B. 
canis merozoite surface antigens (MSA; 2 gene models in B. canis) as well as Bc28 family members (20 gene mod-
els) are highly abundant on the merozoite surface but are also shed and interact with the iRBC membrane and the 
host’s immune system30, 31. Currently, two members of the Bc28 gene family are characterized as major merozoite 
surface antigens playing a critical function in the interaction of merozoites with RBC30, 32. The second-largest fam-
ily of exported proteins comprises secreted DnaJ (Hsp40) chaperones (26 members). P. falciparum DnaJ proteins 
have demonstrated roles in remodelling of iRBCs as well as in pathogenesis33, 34. The so-called “secreted anti-
gens” (SA-1 and SA-3, 24 members) comprise yet another family of genes coding for exported proteins. Some SA 
genes have been identified in other Babesia species35–38. pBLAST analysis showed that the B. canis SAs are highly 
homologous (21 of 24 proteins with e-values < 10E-5) to those of B. gibsoni, which also propagates in dogs, and to 
a lesser extent to SAs of B. bigemina (3 of 24 proteins with e-values < 10E-5), which infects bovines. This supports 
the idea that host-specific factors drive expansion and diversification of these orthologous gene families. Thus, 
Figure 2. Comparative analyses of the Babesia canis BcH-CHIPZ genome. (A) Comparison of orthologous 
clusters in four Babesia species and (B) representative Apicomplexa species. The number of orthologous groups 
is indicated in the intersections. The total number of gene-models and clusters for each species is shown in 
brackets. Orthologous gene clusters in (A) are divided into three categories (pie chart colour code:  multigene 
families;  genes with annotations;  hypothetical genes). (C) Maximum likelihood phylogeny showing 
evolutionary relationship between selected Babesia, Theileria and Plasmodium species based on 975 shared 
orthologues in Apicomplexan species. The scale is in substitutions per site.
www.nature.com/scientificreports/
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this gene family appears to be expanded in Babesia species infecting canines. In contrast, genes coding for smORF 
and spherical body proteins (SBP) appear to be specific to B. bovis and are without orthologues in the B. canis 
genome27, 39. Accordingly, these protein families are also only represented in the bovine specific COGs. Proteins 
of the “secreted antigen family”, as the name indicates, are secreted beyond the iRBC and circulate in the blood of 
infected dogs but are otherwise not well characterized31. The predicted B. canis exportome also includes a group 
of 23 protein kinases. Secreted protein kinases and pseudokinases are known virulence factors in toxoplasmo-
sis40–43. Kinases are also secreted into iRBCs in Plasmodium, where they are responsible inter alia for remodelling 
the host cell44, 45. However, functional data related to secreted kinases in Babesia are not available. Nevertheless, 
kinase inhibitors have been identified as potential novel drugs for the treatment of babesiosis in cattle46, 47.
To refine the predicted host-targeted B. canis exportome dataset we analysed the transcript levels of all 509 
selected gene models in parasites harvested from a splenectomised dog. Evidence from a genome-wide RNAseq 
analysis showed transcription of 71.5% of the 509 exportome gene models (FPKM > 10; n = 364) (Fig. 3B). 
Remarkably, only a few members each of the five most abundant exported protein family genes (VESA-, DnaJ-, 
SA-, PK-, and Bc28- multigene families) with potential roles in antigenic variation and immune evasion were 
expressed at high levels (FPKM > 1000). The particular expression profile of the five gene families in this snapshot 
might be due to selection of a few specific phenotypes in the population at the peak of pathogenicity, but it should 
also be considered that the collected blood stage parasites do not represent a synchronously developing popu-
lation. Nevertheless, this finding merits further investigation, in particular in the light of previous observations 
indicating that pathogenicity was associated with expression of a specific subset of VESA- and other exported 
genes in B. bovis infection26.
Figure 3. Exported protein families in Babesia canis. (A) In silico predicted exported protein families. Bar 
colours indicate the predicted route of secretion and/or type of membrane anchoring. cSP: canonical signal 
peptide; aSP: alternative (non-classical) secretory pathway; TM: transmembrane domain; GPI: predicted 
glycophosphatidylinositol anchor. (B) Transcript abundances of exported proteins. Each dot corresponds to 
the transcript abundance (FPKM) for each gene in the family during acute crisis in a splenectomised dog. Red 
bars indicate the median FPKM values in the presented protein family. FPKM: Fragments Per Kilobase of exon 
model per Million mapped reads.
www.nature.com/scientificreports/
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Further in silico characterization of the predicted B. canis exportome revealed a significant number of pro-
teins (210/509) lacking a canonical hydrophobic signal sequence for co-translational insertion into the lumen 
of the endoplasmic reticulum, which is suggestive of non-classical secretion. This export pathway is generally 
known as ‘leaderless protein secretion’48, 49 and was described recently also in P. falciparum50–52. We screened 
the B. canis exportome for additional motifs associated with protein trafficking into the host cell and beyond. 
First, we searched for matches to Plasmodium PEXEL export elements (RxLxE/Q/D) for trafficking beyond the 
parasitophorous vacuolar membrane (PVM)53, 54, which have been also identified in T. gondii and C. parvum27, 55. 
Although Babesia builds a PVM during invasion of RBC it disappears within minutes and the parasite resides 
directly in the host cell cytoplasm56. A comprehensive comparative in silico analysis of protein export across 10 
Apicomplexa species revealed PEXEL-like motifs (PLM) in B. bovis (but not in T. parva) with a role in retention 
of these proteins in so called spherical bodies and release in a cell-cycle dependent manner27. We found hits for 
the B. bovis PEXEL-like motifs within the first 100 N-terminal amino acids in 64.3% of cSP-containing proteins 
and only in 7.6% of predicted alternatively secreted B. canis proteins (Supplementary Data S4). Using a hidden 
Markov model to identify alternative motifs by de novo pattern discovery did not yield any additional hits.
Expression levels of stage-specific genes identifies asexual and sexual Babesia blood stage par-
asites at acute crisis. We collected biological material from three experimentally infected dogs, which all 
showed very similar rapid disease progression consistent with fatal babesiosis (described in ref. 57). The first 
mild clinical signs (e.g. lethargy) preceded acute crisis with early symptoms of septic shock by a maximum of 
27 hours (Supplementary Fig. S3). In spite of the fulminant disease manifestation, a hallmark of canine babesi-
osis is a remarkably low parasitemia12, 58, 59 with typically <2% infected erythrocytes observed in the peripheral 
blood. The asexual erythrocytic stage of the parasite is entirely responsible for the morbidity and mortality asso-
ciated with canine babesiosis. Morphological characterization of blood stage parasites revealed pleiomorphic 
forms in Giemsa-stained blood smears derived from a critically ill dog (Fig. 4A). Small and large ring stages 
were the most frequently detected forms, while only few pear-shaped forms could be identified. To character-
ize the parasite stages in iRBCs from experimentally infected animals on a molecular level in more detail, we 
used the high-throughput RNA-seq data to identify orthologous gene models with stage-specific expression in 
Plasmodium spp. We intersected the list of B. canis gene models with evidence for expression with a list of vali-
dated Plasmodium spp. stage-specifically expressed genes (e-value threshold of 10E-3) (Supplementary Data S5). 
We found evidence for RNA-seq reads (threshold FPKM > 10) mapping to 22 of 29 conserved merozoite, and 4 
of 7 early gametocyte genes in a blood sample collected from a splenectomised dog (Fig. 4B). The higher mRNA 
abundance of merozoite- (proliferative stage) compared with early gametocyte-specific orthologues (sexual stage) 
during severe disease was consistent with the microscopy data and suggested only marginal numbers of circulat-
ing sexual stages in this peripheral blood sample. Nevertheless, some evidence for early gametocyte stages was 
found, which could indicate that acute clinical crisis in infected dogs might trigger development of sexual stages. 
For example in Plasmodium, gametocyte formation occurs in bone marrow and aggravates clinical symptoms 
and disease outcome60, 61. A potential bone marrow tropism could explain many typical clinical signs in canine 
babesiosis, e.g. leukopenia and thrombocytopenia, associated with poor outcome in acute infections57. B. canis 
orthologues of the 18 identified invertebrate stage-specific proteins (flagellar “late” gametocyte-, ookinete- and 
sporozoite genes) described for Plasmodium had FPKM values between 0 and 10.8, indicating that no or only 
insignificant amounts of these mRNAs were present in the sampled parasite population. Based on the degree of 
Figure 4. Specification of B. canis blood stages. (A) Representative Giemsa-stained blood smears from an 
experimentally infected dog with severe shock-like clinical signs showing typical pleiomorphic morphological 
appearance of B. canis parasites (parasitemia of 1.5% infected erythrocytes). (B) Transcriptome analysis of 
B. canis homologs of validated Plasmodium spp. stage-specific genes in a blood sample collected from an 
experimentally infected splenectomised dog with clinical signs consistent with acute canine babesiosis.
www.nature.com/scientificreports/
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orthologue conservation and the microscopy data we interpret this as paucity of late gametocyte stages in the 
peripheral blood (Supplementary Data S5).
Shotgun proteomics and transcriptomics identify potential B. canis-specific secreted virulence 
factors during severe disease. Proteins involved in parasite-host interactions at acute crisis were identi-
fied by a comparative shotgun approach from B. canis infected and healthy host blood samples. Mass spectrom-
etry datasets were generated from secreted soluble factors collected from pooled short-term cultures from three 
experimentally infected dogs at acute crisis and RBC cultures derived from healthy blood donors, as well as from 
RBC membrane fractions from experimentally infected animals and non-infected controls. We identified a set 
of abundant parasite-specific proteins in these fractions after filtering the data with the non-infected control 
sets. Based on their abundance in the iRBC and/or culture supernatant the identified secreted membrane-bound 
and soluble parasite proteins were considered candidate factors involved in host-pathogen interaction (Table 2; 
Supplementary Fig. S2).
Not surprisingly, considering the limited understanding of apicomplexan pathogenicity determinants, the 
resulting B. canis dataset of exported proteins comprises 47.8% (11/23) proteins annotated as “hypothetical”. In 
addition, the following hits to functionally annotated proteins were identified: factors on cell surface membranes 
(from the parasite or the iRBC) which include 2 variant erythrocyte surface antigens (VESA) located on the 
surface of iRBC, a Babesia spp. membrane protein (homologous to B. bovis, B. microti, B. bigemina, Theileria 
annulata, T. equi, T. orientalis, T. parva, and Cytauxzoon felis), a spectrin repeat superfamily extracellular matrix 
binding protein with homology to B. bovis VESA, and 2 merozoite surface antigens of the Bc28 gene family. These 
proteins where shown to be involved in survival and virulence of several hemoprotozoa species10, 18, 19, 30, 62, 63. 
The dataset comprises SA1 and SA3, belonging to the above described third-largest exported family of proteins 
(secreted antigen family) suggesting a direct role in host-parasite interaction. The B. canis dataset also contains 
profilin, a secreted virulence factor described in P. falciparum and T. gondii with important roles in the pro-
cess of crossing biological barriers during host cell invasion and egress64, 65, a SET-domain containing protein 
with putative function in lateral gene transfer in apicomplexans66, and a SNARE protein mediating membrane 
fusion of secretory vesicles with the plasma membrane67, 68. Furthermore, a secreted histone protein (classified 
as DNA-binding protein) was detected. Histone proteins were described to have moonlighting functions outside 
of the nucleus in P. falciparum, specifically at the interface between parasite and erythrocyte cytoplasm, i.e. the 
parasitophorous vacuole membrane69.
All hits in the proteomic dataset for which GO descriptions or blast homologies could be assigned were fur-
ther validated using transcriptome evidence (threshold FPKM value > 10). Only Bc28.2, a known secreted B. 
canis-specific protein30 with a measured FPKM of 4.5, fell below this threshold. However, the correlation between 
transcript- and protein abundance is not linear and there is a complex relationship leading to notable discrep-
ancies due to a range of factors such as protein- and mRNA turnover70. Taken together with additional evidence 
from the literature, these proteins are good candidates for factors that are presented to the host on the parasite or 
iRBC surface, or released in to the bloodstream and potentially involved in parasite persistence and virulence.
Discussion
Secreted soluble and membrane-targeted parasite proteins have important roles at the host-parasite interface and 
are frequently virulence and pathogenesis factors. Systematic investigation of these interactions in infections with 
potentially fatal blood-borne parasites, such as Babesia canis, which modify the host cell, its microenvironment, 
as well as host physiology in multiple ways, is a challenge. Moreover, these questions cannot be addressed with 
biological material from regular patients from an animal clinic and the parasite is difficult to cultivate. Hence, in 
this study, we used experimental infections of dogs in a controlled setting to gather data on disease progression, 
clinical parameters, and parasite development. We report the first genome and gene expression data of the api-
complexan B. canis with a focus on exported factors secreted during acute infection. Acute B. canis infection with 
fulminant disease progression is associated with high mortality and characterized by an excessive inflammatory 
response caused by protozoal sepsis. This is caused by dysregulation of pro- and anti-inflammatory mechanisms 
during the acute phase of the disease, resulting in shock and end-organ failure71–73 (Supplementary Fig. S3). 
Interestingly, fatal B. canis infections (natural and experimentally induced) are invariably associated with at most 
moderate non-haemolytic anaemia and very low parasitemia12, 57, 59. This strongly suggests that potent secreted 
parasite factors are responsible for the severe pathogenicity of canine babesiosis. Hence, these as yet uncharacter-
ized, secreted virulence factors are prime targets for the development of vaccines but also diagnostic reagents as 
a prime goal in clinical research.
Several major secreted factors inducing acute pathogenicity or persistence of hemoprotozoan parasites have 
been described in P. falciparum and B. bovis74. Following RBC invasion, B. bovis exports VESA proteins to the 
surface of the host cell modifying the iRBC membrane to induce cytoadherence of iRBC at capillary and post-
capillary venous endothelia75–77. VESA expression is subject to rapid antigenic variation defined as the serial 
clonal replacement of the expressed VESA gene in daughter merozoites before invasion of a new RBC. This 
gives rise to antigenically distinct parasite populations, which complicates mounting of an effective host immune 
response. Antigenic variation, i.e. exclusive sequential expression of surface antigen family members is likely a 
sub-phylum-specific immune-evasion strategy in hematozoa documented in several Babesia and Plasmodium 
species including B. rodhaini, B. microti, B. bigemina, P. falciparum and P. vivax8, 78. Not surprisingly, the largest 
exported protein family in B. canis consists of the variant erythrocyte surface antigen (VESA) proteins. Indeed, 
a recent study using comparative transcriptomics and proteomics of attenuated and virulent B. bovis strains 
showed a significantly increased diversity of upregulated VESA genes in virulent strains26. In the present study, 
we detected a high number (74/103) of transcribed VESA genes as well as their products in the B. canis secreted 
proteome. Hence, adherence of B. canis iRBC to endothelial cells is one explanation for the apparent discrepancy 
www.nature.com/scientificreports/
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Identification GO-description1 SP TM GPI AS
Apicomplexan 
orthologue2
Transcriptome 
evidence 
(FPKM)
Specific B. canis secreted soluble proteins:
 BcH000240 Hypothetical protein, conserved 1 6 0 0 no (0.7)
 BcH000493 Hypothetical protein [VESA] 0 0 0 1
VESA (B. bovis 
BBOVII004140) yes (673.5)
 BcH001113 Hypothetical protein, conserved 0 0 0 0 yes (544)
 BcH002928 hypothetical protein, conserved 1 0 0 0 yes (64.2)
 BcH003445 Secreted antigen 3 0 0 0 1 Secreted antigen 3 (B. gibsoni BAH70325) yes (26.4)
 BcH000300 Merozoite surface protein (Bc 28.2) 1 0 0 0 B. canis specific no (4.5)
 BcH002050 SET domain-containing protein 0 0 0 0
SET- and MYND domain 
containing protein, 
putative (B. bigemina 
BBBOND0302680)
yes (147.6)
 BcH002986 hypothetical protein 0 0 0 0 yes (60.1)
 BcH003048 Profilin 0 0 0 0
Polypeptide of 
profiling (B. bigemina 
BBBOND_0104160)
yes (100.6)
 BcH002141 Snare protein 0 1 0 0
Snare protein, 
putative (B. bigemina 
BBOND0107960)
yes (236.6)
 BcH000974 Hypothetical protein, conserved 1 0 0 0
VESA (B. bovis BBOV_
III006920) no (4.1)
 BcH000821
Spectrin repeat 
superfamily extracellular 
matrix binding
0 1 0 0 VESA (B. bovis BBOV_II004140) yes (123.2)
 BcH000175 Hypothetical protein, conserved 0 0 0 0 yes (57.9)
 BcH002958 Hypothetical protein [membrane protein] 0 0 0 1
Membrane protein, 
putative (B. bigemina 
BBBOND_0105580)
yes (56.4)
Specific B. canis host-RBC membrane presented proteins:
 BcH000821
Spectrin repeat 
superfamily extracellular 
matrix binding
0 1 0 0 VESA (B. bovis BBOV_II004140) yes (123.2)
 BcH000300 Merozoite surface protein (Bc 28.2) 1 0 0 0 B. canis specific no (4.5)
 BcH000299 Merozoite surface protein (Bc 28.1) 1 1 1 0 B. canis specific yes (18.3)
 BcH002699 Histone h2a 0 0 0 0
41-2-protein 
antigen precursor, 
putative (B. bigemina 
BBBOND_0103700)
yes (31.9)
 BcH001932 Hypothetical protein, conserved 0 0 0 0 (yes 12.5)
 BcH002268 Hypothetical protein, conserved 0 0 0 0 yes (111.9)
 BcH001655 VESA 0 0 0 1 VESA (B. bovis BBOV_IV002850) yes (884.1)
 BcH001448 Hypothetical protein, conserved 0 0 0 0 no (0.9)
 BcH003376 Secreted antigen 1 0 1 1 1 Secreted antigen 1(B. gibsoni ALE14558) yes (142.5)
 BcH000391 Hypothetical protein, conserved 1 0 0 0 yes (331.2)
 BcH000895 Hypothetical protein, conserved 0 0 0 0 yes (26.4)
Table 2. List Babesia canis specific candidates from culture supernatant derived and membrane-bound 
fractions. GO: gene ontology; SP: signal peptide; TM: transmembrane domain; GPI: AS: alternative secretion: 
GPI: glycophosphatidylinositol: VESA: variant erythrocyte surface antigen. 1Automated annotation by 
Blast2GO; [if no Blast2GO annotation could be assigned, best pBlast hit was provided in brackets]. 2Other than 
hypothetical.
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between the low parasitemia observed in peripheral blood samples and the severity of the disease, consistent 
with sequestration of parasites and removal from the peripheral circulation. Correspondingly, using parasites 
isolated from a peripheral blood sample for the transcriptomic and proteomic studies might introduce a bias with 
respect to the detection of important pathogenicity factors. Direct comparison of proteomic and transcriptomic 
data has to be interpreted with caution, since the RNA-seq data was generated from parasites isolated from a 
splenectomized animal. The peripheral blood of splenectomized individuals would present a dominance of a 
sub-population of mature asexual and immature sexual parasites in iRBCs that failed to sequester, because they 
are not expressing appropriate ligands for cytoadherence, as repeatedly demonstrated in human P. falciparum79, 80. 
Modulation of the adhesive properties of iRBCs by the spleen has been discussed, although no underlying mech-
anism has been identified81, 82. For example, in splenectomized rhesus monkeys infected with Plasmodium know-
lesi a vast reduction in the expression of SICAvar genes, corresponding to their immunovariant adhesins, was 
demonstrated83. In contrast, P. vivax which preferentially invades reticulocytes passage all asexual blood stages 
through the spleen and show spleen-specific cytoadherence important for the development of a chronic disease 
by encoding equivalent vir-genes8. Nevertheless, the responsible Plasmodium var/vir- and the Babesia ves genes 
differ in structure, sequence, and in their biochemical properties74. In contrast to in P. falciparum var genes, 
B. bovis appears to antigenically vary its surface by a combination of segmental gene conversion events from inac-
tive ves genes into an actively transcribed locus with in situ gene switching (clonal activation of genes)84.
Shedding of extracellular (exosome-like) vesicles (EVs) as carriers for proteins, lipids and RNA for intra- 
and inter-species communication (reviewed in refs 85 and 86) was identified recently as a non-classical export 
pathway for a completely new class of important parasite-derived factors. In P. falciparum infections, the concen-
tration of EVs in the blood is positively correlated with severe disease suggesting an important role in pathogen-
esis and immune modulation87. Strikingly, the B. canis BcH-CHIPZ genome encodes homologues of important 
structural proteins and enzymes frequently found in exosomes, including heat shock proteins (e.g. HSP70 and 
90), tetraspanins and ALIX protein, TSG101/ESCRT protein, 14-3-3 protein, thioredoxin peroxidase, histones, 
and the RAB GTPases 5, 7, 11, as well as a RAB GDI85, 88, 89. Due to the mechanism for their biogenesis, exosomes 
often contain endosome-associated proteins, such as the SNARE proteins also detected in the B. canis culture 
supernatant. In P. falciparum, a SNARE protein was localized proximal to the plasma membrane where it is pos-
sibly involved in membrane trafficking events associated with the parasite’s food vacuole68. Hence, EVs in B. canis 
infections could be crucial vehicle carriers for the dissemination of pathogenicity factors that are linked to acute 
and severe disease, including coding and non-coding RNA which can interfere with host cell gene expression. 
In fact, secretion via EVs could account for many of the non-classically secreted proteins detected in the B. canis 
proteomic datasets.
We identified several proteins with moonlighting functions which have been identified as virulence factors 
in related Apicomplexa. For example profilin (pfn) was shown to have important roles in the process of crossing 
biological barriers during host cell invasion and egress, in addition to its classical role as a regulator of actin 
dynamics65. The structure of the P. falciparum pfn accommodates additional domains with as yet unknown func-
tions, which are potentially involved in the parasite-host interplay64. Another interesting finding was a histone 
protein in the iRBC membrane fraction. In several Plasmodium species, a histone protein methylated at position 
L9 was detected in the PV membrane69. The conserved PVM localization in Plasmodium indicated that histones 
have evolved additional functions in invasion and interaction with the host. As Babesia are not contained within 
a PV, the potential moonlighting function of this protein will have to be further investigated. Furthermore, his-
tones are commonly found in EVs90. We also detected a B. canis SET-domain containing protein (BcSET) in the 
secreted soluble fraction. SET proteins are involved in diverse mechanisms such as transcriptional regulation, 
enhancer function, mRNA splicing, DNA replication, and DNA damage response91. An exported SET exerting an 
immune-suppressive function by transcriptional silencing of host gene expression was described in the pathogen 
Bacillus anthraxis92. Interestingly, deregulation of gene expression due to SET domain-containing proteins is 
correlated with unfavourable clinical outcomes in various forms of cancer93.
Members of the Bc28 and SA gene families are among the most prominent B. canis secreted factors, and 
have recently gained attention as candidates for innovative vaccine strategies and in diagnostics30, 31. Bc28 gene 
products are highly represented on the merozoite surface, but are also shed and can interact with the iRBC mem-
brane30. Bc28 belong to a multigene family composed of polymorphic genes. Different B. canis strains in Europe 
are associated with different mortality rates and show genetic heterogeneity in Bc28.1, detectable by a PCR-RFLP 
test18. It has been suggested that this variable repertoire has evolved to allow the parasite to evade host immune 
responses, although merozoite surface proteins of Babesia spp. are thought to be the main targets of the adaptive 
host immune response32, 94. However, whether all members are directly involved in immune evasion and viru-
lence, or even show stage-specific behaviour, will have to be investigated in more detail.
In the absence of reverse genetic techniques for B. canis, sequencing and annotation of a virulent B. canis 
strain together with the described parasite blood stage proteome and transcriptome provides a powerful under-
pinning for designing targeted intervention strategies such as the development of novel diagnostic tools, effective 
vaccines, and innovative drugs.
Methods
Parasites. Biological materials for the different experiments were collected from experimentally infected 
dogs. Animals were inoculated intravenously with 1 × 106 parasitized erythrocytes from a cryo-conserved field 
isolate, derived from a naturally infected Bernese mountain dog from Switzerland that had been exposed during 
a trip to Hungary. All experimentation with animals and protocols was in complete compliance with the strict 
Swiss animal welfare standards and regulations and approved by the responsible authorities (Veterinary Office 
of the Canton of Zurich; permission number 122/2012) previous to the study, including round the clock surveil-
lance of the animals by a veterinarian. Whole blood was treated with citrate-phosphate-dextrose-adenine (12.3% 
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CPDA-1, v/v) for anticoagulation under sterile conditions and prepared immediately after euthanasia. Blood sam-
ples for genomic and transcriptomic studies were collected from an experimentally inoculated splenectomised 
dog (4 years old). Splenectomy increased the final amount of parasites in the peripheral blood to approximately 
4% infected erythrocytes. The biological material for the proteome analysis was collected from three experimen-
tally infected adult beagles with a parasitemia of 1–1.75% (Supplementary Fig. S3). All samples were collected at 
the first signs of acute crisis detected by any clinical signs of acute shock or central nervous depression.
Genome sequencing, assembly, and annotation pipeline. Genomic DNA (gDNA) was prepared 
from purified and host leukocyte-depleted95 infected blood from an experimentally infected, splenectomised dog. 
High-throughput genome sequencing was performed on a PacBio Single Molecule Real Time (SMRT) sequenc-
ing platform96 run on 4 SMRT cells. 5 μg of input gDNA was used for library construction. Sequenced fragments 
were filtered to eliminate Canis familiaris reads and processed for assembly with PacBio read-alignment software 
BLASR97. The final draft of the genome was obtained using a two-step procedure. De novo assembly was initially 
performed using the HGAP2 algorithm98 and the outcome was further polished using the PacBio proprietary 
analysis package Quiver, a reference-guided consensus tool used as part of the SMRT analysis. The resulting 
draft was subjected to gap-closing and further scaffolding using PBJelly v14.1.1599. Genome annotation was per-
formed using different sources of evidence-based prediction on the Maker2 pipeline100, on ab initio gene predic-
tor algorithms101 with P. falciparum 3D7102, B. bovis T2Bo19, and T. annulata Ankara103 gene models as templates 
retrieved from EuPathDB release 26104, and on Trinity-assembled de novo transcriptome evidence105. Repetitive 
genomic elements were identified and masked from annotation with RepeatMasker using the full Repbase data-
base106. Redundant transcripts potentially representing sequencing errors or genetic polymorphisms were clus-
tered with the cd-hit software107. Non-overlapping sequences of the different evidence datasets were generated 
from the gff-files with BEDTools genome arithmetic software108. Functional annotation of the gene-predictions 
was achieved by gene ontology mapping through Blast2Go v3.1109 using an upper cut-off e-value of <0.0005.
Full methodological details are provided in the Supplementary Material.
RNA preparation and RNA-seq data analysis. Total RNA was prepared from host leukocyte-depleted 
B. canis blood stages using the Zymo Direct-zol RNA MiniPrep kit (Zymo Research) including an on-column 
DNase I (QIAGEN) digest. Paired-end, stranded sequencing of the cDNA library was performed on 1 lane of an 
Illumina HiSeq 2000 sequencer (Illumina Inc.). Measurement of expression level was based on fragments per 
kilobase of exon model per million mapped reads (FPKM), normalized by the length of the gene. A gene was 
considered expressed if its FPKM was at least 10. Full methodological details are provided in the Supplementary 
Material.
Summary of computational genome analysis. The identification of potential homologues of B. canis 
genes to selected apicomplexan parasites (B. bovis T2Bo19, B. bigemina BOND39, B. microti RI20, T. annulata 
Ankara103, P. falciparum 3D7102, and T. gondii ME4923) was carried out by protein BLAST (Blast + executables 
v2.2.31) of each individual protein sequence. A e-value < 0.001 cut-off was considered appropriate. For compar-
ative genomics analysis of species-specific genes and clustering of orthologues, OrthoMCL (v2.0.9) was used110, 
111. Synteny analysis was performed in MCScanX112 by the pairwise determination of syntenic regions between 
species based on the order of orthologues from the OrthoMCL output with default values. B. canis contigs were 
arranged according to the syntenic relationship to B. bovis with ‘orderchr’ execution in Circos utilities. The 
graphical representation was made with Circos113. Whole genome phylogeny was based on the 975 identified 
OrthoMCL-orthologues shared among Apicomplexan species. Each of these gene models in 4 Babesia sp. (B. 
canis, B. bovis, B. bigemina, and B. microti), 2 Theileria sp. (T. annulata and T. equi), 2 Plasmodium sp. (P. falci-
parum and P. vivax) and Toxoplasma gondii was aligned using MAFFT v7114. Highly variable sites were trimmed 
using trimal115. A supermatrix of the alignments was concatenated using FASconCAT116. Based on this align-
ment a maximum likelihood phylogenetic tree was constructed using RAxML117, 118 based on amino acid input, 
gamma model, LG substitution matrix and 100 initial bootstrap (bootstrap percentage support is shown along the 
branching nodes), whereas the tree was rooted using T. gondii as an outgroup. Prediction of the B. canis expor-
tome was based on several in silico analysis tools, databases, and manual curation (Supplementary Fig. S1). Full 
methodological details are provided in the Supplementary Material.
Proteomic studies. Proteomic analyses were based on secreted soluble Babesia antigens and 
membrane-bound B. canis proteins. Culture supernatant was collected after 18 h of short term in vitro parasite 
cultures of B. canis RBC in serum-free medium prepared from anticoagulated whole blood from experimentally 
inoculated dogs. Similarly, blood from a healthy canine blood donor was cultured and supernatant was processed 
as a control. Isolation of membrane bound proteins was based on anticoagulated, leucocyte-depleted blood. iRBC 
were concentrated by Percoll (GE Healthcare) gradient centrifugation119 and parasites were released from the 
iRBC by streptolysin-O mediated lysis120 and removed by an additional Percoll gradient centrifugation step121. 
Membrane proteins were collected by homogenization and repeated ultracentrifugation steps, mild sonication 
and acetone precipitation. The same protocol was used to collect proteins from uninfected erythrocyte mem-
branes. All samples were collected and stored at −80 °C until further use.
Protein preparations were separated on one dimensional SDS-PAGE under sterile and reducing conditions. 
Each stained gel was cut into 8 equal sections and in-gel trypsin digestion was carried out for subsequent mass 
spectrometry analysis. Liquid chromatography-MS/MS was performed on a Q-exactive mass spectrometer 
(Thermo Scientific) equipped with a nanoAcquity UPLC (Waters Corporation).
Following peptide data acquisition, searches were performed using the MASCOT search program against a 
database built on the B. canis annotated genes with a concatenated decoy database supplemented with commonly 
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observed contaminants and the Swissprot database to increase database size, or against NCBI database for Canis 
lupus familiaris. Identified hits were filtered in Scaffold Viewer V4 (Proteome Software, Portland, US) based on 
stringent parameters to reach false discovery rates of <5%. Furthermore, all datasets were corrected for obvious 
host- and environmental contaminants by an additional pBLAST search of the NCBI non-redundant protein 
sequences database with the single peptide hits.
Data Availability. The annotated B. canis genome will be made accessible via PiroplasmaDB hosted by 
EuPathDB (http://piroplasmadb.org/piro/).
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